AstraZeneca PLC Equity-NMS: AZN

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$82.34
Open :	$82.18
Today's high :	$82.55
Today's low :	$81.5
52W low :	$60.8253
52W high :	$86.57
1Y :	12.04%
5Y :	58.54%
EPS(TTM): :	2.66
Shares O/S :	3.1 B
Market cap :	255.48 B

What is the share price of AstraZeneca PLC today?

AstraZeneca PLC (AZN) share price as of November 3, 2025, is $82.4. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AstraZeneca PLC?

Yes, Indian Investors can invest in the AstraZeneca PLC (AZN) Share by opening an international trading account with Angel One.

How can I purchase AstraZeneca PLC shares in India?

Purchasing AstraZeneca PLC (AZN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying AstraZeneca PLC (AZN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AstraZeneca PLC?

Yes, you can purchase fractional shares of AstraZeneca PLC (AZN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AstraZeneca PLC?

The market capitalization of AstraZeneca PLC on November 3, 2025, is $255.48 B.

In which sector AstraZeneca PLC belongs?

AstraZeneca PLC operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in AstraZeneca PLC stocks?

In order to invest in AstraZeneca PLC (AZN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.